T0	Participants 80 117	patients with advanced breast cancer:
T1	Participants 379 430	in patients with breast cancer with bone metastases
T2	Participants 549 568	placebo (n = 1,026)
T3	Participants 656 675	placebo (n = 1,020)
T4	Participants 1684 1733	in patients with breast cancer metastatic to bone
T5	Participants 1908 1941	for patients with bone metastases